text: <unk>  is an antidepressive agent that is FDA approved for the {{{indicationType}}} of major depressive disorder, obsessive compulsive disorder, bulimia nervosa, panic disorder,<unk>  Capsules USP and olanzapine in Combination for treatment of depressive episodes associated with bipolar I disorder. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include abnormal dreams, abnormal ejaculation, anorexia, anxiety, asthenia, diarrhea, dry mouth, dyspepsia,<unk> u syndrome, impotence, insomnia, libido decreased, nausea, nervousness, pharyngitis, rash, sinusitis, somnolence, sweating, tremor, vasodilatation, and yawn.
option_0: Fluoxetine
option_1: Atomoxetine
option_2: Duloxetine
option_3: Dapoxetine
option_4: Norfluoxetine
option_5: Vortioxetine
option_6: Bupropion
option_7: Citalopram